AMN Healthcare shareholders approved director elections, executive compensation, KPMG ratification, and Amendment No. 1 to the 2025 Equity Plan increasing shares by 1,420,000 at the May 1, 2026 Annual Meeting.
Key takeaways
Shareholders elected all nine directors, with Sylvia D. Trent-Adams receiving the lowest support at 27.7 million For votes.
Amendment No. 1 to 2025 Equity Plan approved, increasing authorized shares to 2,258,714.
Advisory vote approved named executive officer compensation with 22.7 million For vs. 7.1 million Against.
KPMG LLP ratified as auditor for fiscal year ending December 31, 2026 with 33.2 million For votes.
Shareholder proposal for Independent Board Chairman rejected with 7.5 million For vs. 22.3 million Against.